Israel launches new airstrikes on Lebanon as leaders draw closer to ceasefire with Hezbollah

DAYTONA BEACH, Fla. (AP) — David Early scored 10 points as Radford beat Chicago State 63-48 on Monday. Early shot 3 of 6 from the field and 4 of 4 from the free-throw line for the Highlanders (5-2). Isaiah Gaines, Truth Harris and Jarvin Moss all added nine points. Jalen Forrest finished with 12 points and six rebounds for the Cougars (0-7). The Associated Press created this story using technology provided by Data Skrive and data from Sportradar .West Virginia knocks off No. 3 Gonzaga 86-78 in overtime in the Battle 4 Atlantis

Styrenic Block Copolymer Market Intelligence Report Offers Key Futuristic Top Trends, Research Methodology and Competitive Landscape By 2030 12-02-2024 09:19 PM CET | Business, Economy, Finances, Banking & Insurance Press release from: Orion Market Research Styrenic Block Copolymers (SBCs) are a unique class of thermoplastic elastomer (TPE) materials that bridge the gap between rubber and plastic. They consist of hard styrene blocks providing strength and rigidity, and soft elastomeric blocks offering elasticity and flexibility. Get Free Sample link @ https://www.omrglobal.com/request-sample/styrenic-block-copolymers-market The primary driver is the rising demand from end-user sectors of SBC such as footwear, construction (asphalt modification), adhesives & sealants, and medical devices. This is fueled by factors like increasing disposable income, infrastructure development, and growing urbanization, particularly in developing economies. Thus, in order to meet the growing demand, in September 2022, Kraton Corp. has announced an expansion project for high flow hydrogenated styrenic block copolymer (HSBC) products at its joint venture manufacturing facility in Mailiao, Taiwan. full report of Styrenic Block Copolymer Market available @ https://www.omrglobal.com/industry-reports/styrenic-block-copolymers-market Market Coverage Market number available for - 2024-2031 Base year- 2023 Forecast period- 2024-2031 Segment Covered- By Source, By Product Type, By Applications Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill , and others Market Segmentation Global Styrenic Block Copolymer Market by Product Hydrogenated Styrenic Block Copolymers (HSBC) Styrene-Butadiene-Styrene (SBS) Styrene-Isoprene-Styrene (SIS) Global Styrenic Block Copolymer Market by Application Asphalt Modification Footwear Polymer Modification Adhesives and Sealants Other Applications Regional Analysis North America United States Canada Europe UK Germany Italy Spain France Rest of Europe Asia-Pacific China India Japan South Korea Rest of Asia-Pacific Rest of the World Latin America The Middle East & Africa Company Profiles CHIMEI H China Petroleum & Chemical Corporation (Sinopec) Denka Company Ltd. Dynasol Group En Chuan Chemical Industries Co., Ltd. Fujian Gulei Petrochemical Co. INEOS Styrolution Group GmbH JSR Corp. Korea Kumho Petrochemical Co., Ltd. KRATON CORP. Kuraray Co., Ltd. LG Chem SIBUR TSRC Versalis S.p.A. Zhejiang Zhongli Synthetic Material Technology Co., Ltd. The Report Covers Market value data analysis of 2023and forecast to 2031. Annualized market revenues ($ million) for each market segment. Country-wise analysis of major geographical regions. Key companies operating in the global SBC market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report. Analysis of business strategies by identifying the key market segments positioned for strong growth in the future. Analysis of market-entry and market expansion strategies. Competitive strategies by identifying 'who-stands-where' in the market. For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/styrenic-block-copolymers-market Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404 About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies. This release was published on openPR.President Biden’s decision to renege on his pledge not to pardon his prodigal son’s crimes has consequences for the American justice system. Ironically, it also may diminish resistance to President-elect Trump pardoning members of the mob that stormed the Capitol nearly four years ago in an effort to overturn Biden’s 2020 election victory. The two situations are not equivalent, of course. Still, they both tear at the heart of America’s scruples. More than 1,100 Trump supporters got convicted of participating in the siege that sent a joint session of Congress into hiding, injured scores of police officers and left the Capitol in a shambles. Several defendants received probation for misdemeanor charges of entering the Capitol with the mob. But more than 600 were imprisoned from one month to up to 22 years on felony charges of destroying property, assault and battery or encouraging the attack. Trump described them as “political prisoners” and “patriots,” promising to pardon them if elected president again. He said recently he will decide their pardons on a case-by-case basis. A song titled “Justice for All” described their fate. Created and posted often on social media by a group of Jan. 6 defendants (“J6 Choir”) locked in a Washington, D.C. jail block, the song’s popularity drew sympathizers across the country. It briefly made music’s top hits list. Democrats and legal experts denounce Tump’s plan to pardon Jan. 6 defendants as victims of misguided justice. The objection is somewhat hypocritical in the aftermath of Biden pardoning son Hunter. He was convicted of lying on a gun license application and income tax evasion. What devastates the rule of law is Biden’s broken pledge to let his son face the consequences of his felony crimes, including possible prison time. His stunning turnaround occurred, he said, because his son was a victim of a Justice Department political prosecution. That’s the exact reason Trump advances for his intent to pardon some, if not all, the Jan. 6 defendants. He also claims that’s why he was prosecuted and convicted of 34 felonies in his hush money trial as well as charges pending in his other legal cases. Oddly, it seems Biden and Trump agree the Justice Department has been weaponized for political means. Trump says when he returns to office he will rid the department, including its FBI office, of what he calls partisan hacks bent on destroying the country. They will, of course, be replaced by diehard loyalists committed to his America First agenda. Democrats can hardly object. Their president of the last four years has damned the Justice Department and demoralized its employees for his own sake. And just two months before departing the White House. Listen to his attempt to rationalize the decision to pardon his son when he said repeatedly he would not. “For my entire career I have followed a simple principle: just tell the American people the truth. They will be fair-minded,” Biden said in a statement. “Here’s the truth: I believe in the justice system, but as I have wrestled with this, I also believe raw politics has infected the process and it led to a miscarriage of justice (of his son).” Biden asked Americans to understand “why a father and a president would come to this decision.” Many will not. Sure, other presidents, including Trump in his first term, granted pardons to family and friends for alleged criminal behavior. In most of these cases, the persons pardoned felt the outcome of their sentences, including prison time. Biden’s rollback of his no pardon pledge – just two weeks before his son’s sentencing -- disregarded the legal standard that no person is above the law; that everyone is treated equally no matter their station in life. Sadly, Biden’s decision of defiance comes at a time when the justice system’s moral fiber is fraying. Bill Ketter is CNHI’s senior vice president for news. Reach him at wketter@cnhi.com .Liberal candidate in B.C. byelection seeks Métis membership after identity questioned

Prince Andrew says he ‘ceased all contact’ with 'Chinese spy' after concerns raisedGrowing up, Pete Bissonette always wanted to live in a bus or a cave. The latter dream came true, at least in a sense. Bissonette has one of the about 650 homes Mankato, Minnesota-based Earth Sheltered Technology has built since it began in 1981. The company, which has houses in the Twin Cities and Wisconsin as well as in California and Alaska, specializes in partly underground structures, basically man-made caves. Underground homes, also known as earth-sheltered homes, have been around for nearly as long as humans have, though the modern incarnation seemed to gain traction in the 1970s after the 1973 oil embargo and ensuing energy crisis, according to an article in magazine Mother Earth News. At the time, people were looking to reduce energy usage, especially when it came to heating and cooling their homes. Underground homes have other benefits, too, including durability — particularly in the face of natural disasters like tornadoes — and low-maintenance needs (no need to paint when dirt and grass cover the whole house). Perhaps that’s why Earth Sheltered Technology has produced the bulk of its homes, about 450, in the past 17 years, said owner Jeff Hickok. Besides achieving his childhood dream, Bissonette’s other inspiration for building his underground home was the book “Earth Sheltered Housing Design,” published in the late 1970s by the University of Minnesota’s Underground Space Center. John Carmody, one of the leaders of the underground-home movement at the time as a systems designer and environmentalist, oversaw the center and the book, which sold 250,000 copies, according the to university’s website. “I loved every bit of building it,” Bissonette said of his house. “I’m glad I made the decision to build it. I have no intention of ever selling it and made it wheelchair accessible so I can get around in case I need one.” Bissonette said he has long worried about tornadoes. An underground home, he thought, would protect against that. Underground homes are known for their durability, Hickok said. He said at least two tornadoes have gone over his Mankato underground home. It’s a reason his company has been building so many underground houses in Oklahoma and Texas. Texas averages about 140 tornadoes each year, the most of any state, while Oklahoma ranks in the top five, per CNN. Other clients have reported the structures being able to withstand earthquakes, Hickok said. The U.S. Department of Energy’s website said earth-sheltered homes can cost less to insure, as they naturally can withstand high winds, hailstorms, tornadoes and hurricanes. The Australian Broadcasting Co. even published a story last year about such homes gaining popularity because of their ability to withstand high temperatures and bush fires. “The earth is a very good protector for tornadoes,” Hickok said. “A tornado can’t damage a home unless it can completely surround it, and with most underground homes, they only have south-facing windows.” In addition to saving money on a homeowner’s insurance policy, an underground home could also save on claims. Hail, for example, does minimal damage to the roof, with only some of the piping up top suffering damage. Earth Sheltered Technology was a retirement job for Jeff Hickok’s father, Jerry Hickok. Jeff Hickok said his dad had a fascination with living in a cellar as a child and created the company after finishing at his corporate job. As a kid, Hickok dreaded going to home shows with his father and didn’t pursue the business until later in his life, taking it on around 2007. “I didn’t realize how forward-thinking dad really was with energy-saving and safety of these things,” he said. “I’m so proud to be running the company that my father pioneered.” Another big selling point: An underground home uses about 80% less energy than a traditional home of its size. That’s because the ground insulates it to keep it at a stable 50- to 60-degree internal temperature. South-facing windows warm it during the day, Hickok said. Dick and Jeanne Newport of Berlin, Wisconsin, remember the ’70s energy crisis and how people wanted to be energy independent. They visited a friend’s underground home back then and left inspired to have their own one day, which eventually happened in 2016. About 980,000 pounds of solid concrete surrounds their two-bedroom, two-bathroom underground home, and most winters, only a single wood-burning stove heats the 2,000-square-foot property, Dick Newport said. On the roof, the two have planted native grasses. “People thought our house was a septic mound because they didn’t know what it was,” Jeanne Newport said. “Until you get to the front, you can’t tell it’s a house. There’s tall prairie grass all around it, and it’s really hard to see the whole rounded shape.” They estimate they pay about $115 in utilities for their highest-usage month. The average Minnesotan pays more than $151 a month for electric and gas utilities, according to Kris Lindahl Real Estate. The Newports estimated it cost about $350,000 to build their house including all the interior design, electrical and plumbing. When adjusting for inflation, that comes out to $465,799 in 2024. Earth Sheltered Technology builds several concrete dome structures with steel beams as support, insulating and waterproofing them for the price of about $150 per square foot, according to Hickok. But the rest is up to the homeowners to DIY or hire contractors. Having to do extra work didn’t bug the Newports, and the lower energy bills every month make up for the cost of building the home. “There’s not a lot of maintenance because most of the house is covered in dirt, and it’s quiet if the windows are closed,” Dick Newport said. “We have peace of mind living here.” This past summer, a “hobbit house” in Pine Lake Township, Minnesota, listed for about $180,000, drawing attention for its unique underground design. Being different is yet another perk of having an earth-sheltered home for Bissonette, who is working on an art piece made of 5,000 empty wine bottles. Outside of his two-bedroom, two-bathroom, 4,000-square-foot home, there’s a large labyrinth in his yard filled with statues from Bali, including one that can identify evil, Bissonette said. There are also tall native grasses growing on the roof among a smattering of solar tubes and ventilation pipes. His home blends into the surrounding vegetation and looks like several hills with trees and shrubs growing on them. It’s not until visitors turn a corner that they’re able to see two garage doors poking out, alongside a front door, wide driveway and windows. When he built his house in 2001, many of his neighbors thought it looked like a military base because of how hidden it was from the main road. But the rooftop patio makes it perfect for hosting, Bissonette said of the views of rolling farmland and acres of wildlife. Bissonette taught himself and installed much of the electrical work, also repurposing salvaged wood for the interior walls, making it uniquely his own. “What surprises people the most is how light it is in the house,” he said. “They expect it to be dark because it is underground, but the curved interior surface of the domes reflect light throughout the space, bouncing it across the inner surfaces, making it bright and light-filled.” Get local news delivered to your inbox!Bad Axe: Wisconsin wary of rival Minnesota with bowl bid in perilDuke of York ‘ceased all contact’ with spy-accused man after concerns raised

Trump wants to turn the clock on daylight saving timeAndrew met the individual through “official channels” with “nothing of a sensitive nature ever discussed”, a statement from his office said. The businessman – known only as H6 – lost an appeal over a decision to bar him from entering the UK on national security grounds. He brought a case to the Special Immigration Appeals Commission (SIAC) after then-home secretary Suella Braverman said he should be excluded from the UK in March 2023. H6 was described as a “close confidante” of The Duke. Judges were told that in a briefing for the home secretary in July 2023, officials claimed H6 had been in a position to generate relationships between prominent UK figures and senior Chinese officials “that could be leveraged for political interference purposes”. They also said that H6 had downplayed his relationship with the Chinese state, which combined with his relationship with Andrew, 64, represented a threat to national security. A statement from Andrew’s office said: “The Duke of York followed advice from His Majesty’s Government and ceased all contact with the individual after concerns were raised. “The Duke met the individual through official channels with nothing of a sensitive nature ever discussed. “He is unable to comment further on matters relating to national security.” At a hearing in July, the specialist tribunal heard that the businessman was told by an adviser to Andrew that he could act on the duke’s behalf when dealing with potential investors in China, and that H6 had been invited to Andrew’s birthday party in 2020. A letter referencing the birthday party from the adviser, Dominic Hampshire, was discovered on H6’s devices when he was stopped at a port in November 2021. In a ruling on Thursday, Mr Justice Bourne, Judge Stephen Smith and Sir Stewart Eldon, dismissed the challenge.

AP Sports SummaryBrief at 6:31 p.m. EST

NoneDemocrats plan to elect new party leader just days after Trump's inauguration

By JILL COLVIN NEW YORK (AP) — President-elect Donald Trump wants to turn the lights out on daylight saving time. In a post on his social media site Friday, Trump said his party would try to end the practice when he returns to office. “The Republican Party will use its best efforts to eliminate Daylight Saving Time, which has a small but strong constituency, but shouldn’t! Daylight Saving Time is inconvenient, and very costly to our Nation,” he wrote. Setting clocks forward one hour in the spring and back an hour in the fall is intended to maximize daylight during summer months, but has long been subject to scrutiny. Daylight saving time was first adopted as a wartime measure in 1942. Lawmakers have occasionally proposed getting rid of the time change altogether. The most prominent recent attempt, a now-stalled bipartisan bill named the Sunshine Protection Act , had proposed making daylight saving time permanent. The measure was sponsored by Florida Sen. Marco Rubio , whom Trump has tapped to helm the State Department. Related Articles National Politics | Ruling by a conservative Supreme Court could help blue states resist Trump policies National Politics | A nonprofit leader, a social worker: Here are the stories of the people on Biden’s clemency list National Politics | Nancy Pelosi hospitalized after she ‘sustained an injury’ on official trip to Luxembourg National Politics | Veteran Daniel Penny, acquitted in NYC subway chokehold, will join Trump’s suite at football game National Politics | About 3 in 10 are highly confident in Trump on Cabinet, spending or military oversight: AP-NORC poll “Changing the clock twice a year is outdated and unnecessary,” Republican Sen. Rick Scott of Florida said as the Senate voted in favor of the measure. Health experts have said that lawmakers have it backward and that standard time should be made permanent. Some health groups , including the American Medical Association and American Academy of Sleep Medicine, have said that it’s time to do away with time switches and that sticking with standard time aligns better with the sun — and human biology. Most countries do not observe daylight saving time. For those that do, the date that clocks are changed varies, creating a complicated tapestry of changing time differences. Arizona and Hawaii don’t change their clocks at all.

WARRINGTON, Pa., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. ("Windtree” or "the Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions, today reported financial results for the third quarter ended September 30, 2024 and provided key business updates. "The third quarter of 2024 was marked with significant progress. We were very pleased with the SEISMiC B study results in early cardiogenic shock showing significant improvement in many measures of cardiac function and blood pressure along with a favorable safety profile in patients with heart failure and cardiogenic shock. There have been four positive Phase 2 studies with over 300 patients treated with istaroxime resulting in a consistent, unique and attractive drug profile across a wide range of severities,” said Craig Fraser, Chairman and CEO. "With trial execution and active operations comes the need for capital and we successfully completed transactions providing resources for our near-term needs as well as secured an equity line of credit to potentially support future requirements,” Mr. Fraser added. "Looking forward, we plan to accelerate enrollments in the istaroxime SCAI Stage C cardiogenic shock study with a planned interim data read out in early Q2 2025 as well as providing guidance on our strategy and planned activities with our oncology preclinical aPKCi inhibitor assets. Given what we believe to be strong data and market need, the Company is turning attention to business development activities to secure additional licenses and partnerships for our multi-asset cardiovascular platform with the objective to secure non-dilutive capital and partner resources to advance the assets to potential commercialization.” Key Business Updates For the third quarter ended September 30, 2024, the Company reported an operating loss of $4.7 million, which was comparable to an operating loss of $4.7 million in the third quarter of 2023. Included in our operating loss for the third quarter of 2024 is $2.2 million related to the change in fair value of our common stock warrant liability and $0.7 million in expenses related to the two private placements completed in July 2024 which were allocated to the warrants issued in those transactions and expensed immediately. Research and development expenses were $2.0 million for the third quarter of 2024, compared to $2.1 million for the third quarter of 2023. Research and development expenses for both periods primarily relate to the SEISMiC Extension trial of istaroxime for the treatment of early cardiogenic shock which completed enrollment during the third quarter of 2024. General and administrative expenses for the third quarter of 2024 were $2.8 million, compared to $2.6 million for the third quarter of 2023. For the third quarter of 2024, general and administrative expenses include $0.7 million in expenses related to the two private placements completed in July 2024 which were allocated to the warrants issued in those transactions and expensed immediately. The Company reported a net loss attributable to common stockholders of $3.8 million ($4.23 per basic share) on 0.9 million weighted-average common shares outstanding for the quarter ended September 30, 2024, compared to a net loss of $4.4 million ($15.47 per basic share) on 0.3 million weighted average common shares outstanding for the comparable period in 2023. As of September 30, 2024, the Company reported cash and cash equivalents of $2.3 million and current liabilities of $14.4 million, which includes an $8.6 million warrant liability. Included in prepaid expenses and other assets as of September 30, 2024 is $0.7 million in receivables related to ELOC Purchase Agreement gross proceeds for sales made during the quarter for which we had not yet received the cash payment. The related net proceeds after the redemption of the Series C Preferred Stock was $0.5 million. In addition, subsequent to September 30, 2024 and through November 22, 2024, we sold an additional 4.3 million shares of Common Stock under the ELOC Purchase Agreement for net proceeds of $2.4 million following mandatory redemption payments on our Series C Preferred Stock. Following these financings, we believe that we have sufficient resources available to fund our business operations through January 2025. Readers are referred to, and encouraged to read in its entirety, the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2024, which was filed with the Securities and Exchange Commission on November 26, 2024, and includes detailed discussions about the Company's business plans and operations, financial condition, and results of operations. Nasdaq Update On November 21, 2024, the Company received a letter from the Nasdaq Listing Qualifications Staff ("Staff”) of The Nasdaq Stock Market LLC stating that it was not in compliance with Nasdaq Listing Rule 5250(c)(1) as a result of it not having timely filed its Quarterly Report on Form 10-Q ("Form 10-Q”) for the quarter ended September 30, 2024 with the Securities and Exchange Commission. Based on the November 26, 2024 filing of the Company's Form 10-Q and a subsequent letter received from Nasdaq on November 27, 2024 stating the Staff has determined that the Company complies with Nasdaq Listing Rule 5250(c)(1), this matter is now closed. About Windtree Therapeutics, Inc. Windtree Therapeutics, Inc. is a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases. Windtree's portfolio of product candidates includes istaroxime, a Phase 2 candidate with SERCA2a activating properties for acute heart failure and associated cardiogenic shock, preclinical SERCA2a activators for heart failure and preclinical precision aPKCi inhibitors that are being developed for potential in rare and broad oncology applications. Windtree also has a licensing business model with partnership out-licenses currently in place. Forward Looking Statements This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. The Company may, in some cases, use terms such as "predicts," "believes," "potential," "proposed," "continue," "estimates," "anticipates," "expects," "plans," "intends," "may," "could," "might," "will," "should" or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. Such statements are based on information available to the Company as of the date of this press release and are subject to numerous important factors, risks and uncertainties that may cause actual events or results to differ materially from the Company's current expectations. Examples of such risks and uncertainties include, among other things: the Company's ability to secure significant additional capital as and when needed; the Company's ability to achieve the intended benefits of the aPKCi asset acquisition with Varian Biopharmaceuticals, Inc.; the Company's risks and uncertainties associated with the success and advancement of the clinical development programs for istaroxime and the Company's other product candidates, including preclinical oncology candidates; the Company's ability to access the debt or equity markets; the Company's ability to manage costs and execute on its operational and budget plans; the results, cost and timing of the Company's clinical development programs, including any delays to such clinical trials relating to enrollment or site initiation; risks related to technology transfers to contract manufacturers and manufacturing development activities; delays encountered by the Company, contract manufacturers or suppliers in manufacturing drug products, drug substances, and other materials on a timely basis and in sufficient amounts; risks relating to rigorous regulatory requirements, including that: (i) the U.S. Food and Drug Administration or other regulatory authorities may not agree with the Company on matters raised during regulatory reviews, may require significant additional activities, or may not accept or may withhold or delay consideration of applications, or may not approve or may limit approval of the Company's product candidates, and (ii) changes in the national or international political and regulatory environment may make it more difficult to gain regulatory approvals and risks related to the Company's efforts to maintain and protect the patents and licenses related to its product candidates; risks that the Company may never realize the value of its intangible assets and have to incur future impairment charges; risks related to the size and growth potential of the markets for the Company's product candidates, and the Company's ability to service those markets; the Company's ability to develop sales and marketing capabilities, whether alone or with potential future collaborators; the rate and degree of market acceptance of the Company's product candidates, if approved; the Company's ability to maintain compliance with the continued listing requirements of Nasdaq; the economic and social consequences of the COVID-19 pandemic and the impacts of political unrest, including as a result of geopolitical tension, including the conflict between Russia and Ukraine, the People's Republic of China and the Republic of China (Taiwan), and the evolving events in the Middle East, and any sanctions, export controls or other restrictive actions that may be imposed by the United States and/or other countries which could have an adverse impact on the Company's operations, including through disruption in supply chain or access to potential international clinical trial sites, and through disruption, instability and volatility in the global markets, which could have an adverse impact on the Company's ability to access the capital markets. These and other risks are described in the Company's periodic reports, including its Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, filed with or furnished to the Securities and Exchange Commission and available at www.sec.gov. Any forward-looking statements that the Company makes in this press release speak only as of the date of this press release. The Company assumes no obligation to update forward-looking statements whether as a result of new information, future events or otherwise, after the date of this press release. Contact Information: Eric Curtis [email protected] Consolidated Balance Sheets (in thousands, except share and per share data) Consolidated Statements of Operations (in thousands, except per share data)

SUNRISE, Fla. (AP) — Spencer Knight made 20 saves, Mackie Samoskevich scored with less than a second left in the second period, and the Florida Panthers got four goals in the third to beat the Carolina Hurricanes 6-0 on Saturday and complete a two-day sweep. Aleksander Barkov, Sam Bennett, Aaron Ekblad, Evan Rodrigues and Adam Boqvist also scored for Florida, which won 6-3 at Carolina on Friday. The Panthers have won three straight — that streak following a stretch of six losses in seven games for the Stanley Cup champions. It was Knight's fourth career shutout, his first since Nov. 9, 2022 — also at home against Carolina. Spencer Martin made 23 saves on 28 shots for the Hurricanes, who have dropped four of their last six games (2-3-1). It was Martin's fourth consecutive start for Carolina. Hurricanes: This was the first time all season that the Hurricanes failed to get a point in the game immediately following a loss. Carolina was 4-0-1 after a defeat entering Saturday. Panthers: A big day for Samoskevich — his alma mater Michigan beat Ohio State in football on Saturday, that game ending just before the Florida-Carolina game started. The Panthers are 5-0-0 when he scores this season. Sam Reinhart had each of the four most recent Florida goals at 19:59, before Samoskevich got his Saturday. The Panthers scored two goals 11 seconds apart in the third to make it 5-0, and Yaniv Perets replaced Martin in the Hurricanes' net with 8:12 remaining. It was the second NHL appearance for Perets, who came on once in relief for Carolina last season. Ekblad's goal was his first in a span of 1,045 regular-season shifts since Feb. 20. Carolina starts a two-game homestand Tuesday against Seattle. Florida goes to Pittsburgh to start a two-game trip on Tuesday. AP NHL: https://www.apnews.com/hub/NHLUnwrap the latest AI features with Amazon Fire Tablets